Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash

HBM Healthcare Investments AG / Key word(s): Acquisition
Bristol Myers Squibb to Acquire HBM Portfolio Company Turning Point Therapeutics for USD 4.1 billion in cash

03.06.2022 / 17:46


HBM Healthcare Investments today announces that its portfolio company...
Quelle: Börse Online RSS Feed